Importance of perioperative glycemic control in general surgery: A report from the surgical care and outcomes assessment program

Steve Kwon, Rachel Thompson, Patchen Dellinger, Norbert Yanez, Ellen Farrohki, David Flum

Research output: Contribution to journalArticle

208 Citations (Scopus)

Abstract

OBJECTIVE: To determine the relationship of perioperative hyperglycemia and insulin administration on outcomes in elective colon/rectal and bariatric operations. BACKGROUND: There is limited evidence to characterize the impact of perioperative hyperglycemia and insulin on adverse outcomes in patients, with and without diabetes, undergoing general surgical procedures. METHODS: The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement benchmarking-based initiative. We evaluated the relationship of perioperative hyperglycemia (>180 mg/dL) and insulin administration on mortality, reoperative interventions, and infections for patients undergoing elective colorectal and bariatric surgery at 47 participating hospitals between fourth quarter of 2005 and fourth quarter of 2010. RESULTS: Of the 11,633 patients (55.4 ± 15.3 years; 65.7% women) with a serum glucose determination on the day of surgery, postoperative day 1, or postoperative day 2, 29.1% of patients were hyperglycemic. After controlling for clinical factors, those with hyperglycemia had a significantly increased risk of infection [odds ratio (OR) 2.0; 95% confidence interval (CI), 1.63-2.44], reoperative interventions (OR, 1.8; 95% CI, 1.41-2.3), and death (OR, 2.71; 95% CI, 1.72-4.28). Increased risk of poor outcomes was observed both for patients with and without diabetes. Those with hyperglycemia on the day of surgery who received insulin had no significant increase in infections (OR, 1.01; 95% CI, 0.72-1.42), reoperative interventions (OR, 1.29; 95% CI, 0.89-1.89), or deaths (OR, 1.21; 95% CI, 0.61-2.42). A dose-effect relationship was found between the effectiveness of insulin-related glucose control (worst 180-250 mg/dL, best <130 mg/dL) and adverse outcomes. CONCLUSIONS: Perioperative hyperglycemia was associated with adverse outcomes in general surgery patients with and without diabetes. However, patients with hyperglycemia who received insulin were at no greater risk than those with normal blood glucoses. Perioperative glucose evaluation and insulin administration in patients with hyperglycemia are important quality targets.

Original languageEnglish (US)
Pages (from-to)8-14
Number of pages7
JournalAnnals of Surgery
Volume257
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Hyperglycemia
Outcome Assessment (Health Care)
Insulin
Odds Ratio
Confidence Intervals
Ambulatory Surgical Procedures
Glucose
Infection
Bariatrics
Benchmarking
Colorectal Surgery
Bariatric Surgery
Quality Improvement
Blood Glucose
Colon
Mortality
Serum

Keywords

  • Diabetes
  • insulin
  • perioperative hyperglycemia
  • quality improvement

ASJC Scopus subject areas

  • Surgery

Cite this

Importance of perioperative glycemic control in general surgery : A report from the surgical care and outcomes assessment program. / Kwon, Steve; Thompson, Rachel; Dellinger, Patchen; Yanez, Norbert; Farrohki, Ellen; Flum, David.

In: Annals of Surgery, Vol. 257, No. 1, 01.2013, p. 8-14.

Research output: Contribution to journalArticle

Kwon, Steve ; Thompson, Rachel ; Dellinger, Patchen ; Yanez, Norbert ; Farrohki, Ellen ; Flum, David. / Importance of perioperative glycemic control in general surgery : A report from the surgical care and outcomes assessment program. In: Annals of Surgery. 2013 ; Vol. 257, No. 1. pp. 8-14.
@article{985c5cf419e44128912bd888aa5ac1fa,
title = "Importance of perioperative glycemic control in general surgery: A report from the surgical care and outcomes assessment program",
abstract = "OBJECTIVE: To determine the relationship of perioperative hyperglycemia and insulin administration on outcomes in elective colon/rectal and bariatric operations. BACKGROUND: There is limited evidence to characterize the impact of perioperative hyperglycemia and insulin on adverse outcomes in patients, with and without diabetes, undergoing general surgical procedures. METHODS: The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement benchmarking-based initiative. We evaluated the relationship of perioperative hyperglycemia (>180 mg/dL) and insulin administration on mortality, reoperative interventions, and infections for patients undergoing elective colorectal and bariatric surgery at 47 participating hospitals between fourth quarter of 2005 and fourth quarter of 2010. RESULTS: Of the 11,633 patients (55.4 ± 15.3 years; 65.7{\%} women) with a serum glucose determination on the day of surgery, postoperative day 1, or postoperative day 2, 29.1{\%} of patients were hyperglycemic. After controlling for clinical factors, those with hyperglycemia had a significantly increased risk of infection [odds ratio (OR) 2.0; 95{\%} confidence interval (CI), 1.63-2.44], reoperative interventions (OR, 1.8; 95{\%} CI, 1.41-2.3), and death (OR, 2.71; 95{\%} CI, 1.72-4.28). Increased risk of poor outcomes was observed both for patients with and without diabetes. Those with hyperglycemia on the day of surgery who received insulin had no significant increase in infections (OR, 1.01; 95{\%} CI, 0.72-1.42), reoperative interventions (OR, 1.29; 95{\%} CI, 0.89-1.89), or deaths (OR, 1.21; 95{\%} CI, 0.61-2.42). A dose-effect relationship was found between the effectiveness of insulin-related glucose control (worst 180-250 mg/dL, best <130 mg/dL) and adverse outcomes. CONCLUSIONS: Perioperative hyperglycemia was associated with adverse outcomes in general surgery patients with and without diabetes. However, patients with hyperglycemia who received insulin were at no greater risk than those with normal blood glucoses. Perioperative glucose evaluation and insulin administration in patients with hyperglycemia are important quality targets.",
keywords = "Diabetes, insulin, perioperative hyperglycemia, quality improvement",
author = "Steve Kwon and Rachel Thompson and Patchen Dellinger and Norbert Yanez and Ellen Farrohki and David Flum",
year = "2013",
month = "1",
doi = "10.1097/SLA.0b013e31827b6bbc",
language = "English (US)",
volume = "257",
pages = "8--14",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Importance of perioperative glycemic control in general surgery

T2 - A report from the surgical care and outcomes assessment program

AU - Kwon, Steve

AU - Thompson, Rachel

AU - Dellinger, Patchen

AU - Yanez, Norbert

AU - Farrohki, Ellen

AU - Flum, David

PY - 2013/1

Y1 - 2013/1

N2 - OBJECTIVE: To determine the relationship of perioperative hyperglycemia and insulin administration on outcomes in elective colon/rectal and bariatric operations. BACKGROUND: There is limited evidence to characterize the impact of perioperative hyperglycemia and insulin on adverse outcomes in patients, with and without diabetes, undergoing general surgical procedures. METHODS: The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement benchmarking-based initiative. We evaluated the relationship of perioperative hyperglycemia (>180 mg/dL) and insulin administration on mortality, reoperative interventions, and infections for patients undergoing elective colorectal and bariatric surgery at 47 participating hospitals between fourth quarter of 2005 and fourth quarter of 2010. RESULTS: Of the 11,633 patients (55.4 ± 15.3 years; 65.7% women) with a serum glucose determination on the day of surgery, postoperative day 1, or postoperative day 2, 29.1% of patients were hyperglycemic. After controlling for clinical factors, those with hyperglycemia had a significantly increased risk of infection [odds ratio (OR) 2.0; 95% confidence interval (CI), 1.63-2.44], reoperative interventions (OR, 1.8; 95% CI, 1.41-2.3), and death (OR, 2.71; 95% CI, 1.72-4.28). Increased risk of poor outcomes was observed both for patients with and without diabetes. Those with hyperglycemia on the day of surgery who received insulin had no significant increase in infections (OR, 1.01; 95% CI, 0.72-1.42), reoperative interventions (OR, 1.29; 95% CI, 0.89-1.89), or deaths (OR, 1.21; 95% CI, 0.61-2.42). A dose-effect relationship was found between the effectiveness of insulin-related glucose control (worst 180-250 mg/dL, best <130 mg/dL) and adverse outcomes. CONCLUSIONS: Perioperative hyperglycemia was associated with adverse outcomes in general surgery patients with and without diabetes. However, patients with hyperglycemia who received insulin were at no greater risk than those with normal blood glucoses. Perioperative glucose evaluation and insulin administration in patients with hyperglycemia are important quality targets.

AB - OBJECTIVE: To determine the relationship of perioperative hyperglycemia and insulin administration on outcomes in elective colon/rectal and bariatric operations. BACKGROUND: There is limited evidence to characterize the impact of perioperative hyperglycemia and insulin on adverse outcomes in patients, with and without diabetes, undergoing general surgical procedures. METHODS: The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement benchmarking-based initiative. We evaluated the relationship of perioperative hyperglycemia (>180 mg/dL) and insulin administration on mortality, reoperative interventions, and infections for patients undergoing elective colorectal and bariatric surgery at 47 participating hospitals between fourth quarter of 2005 and fourth quarter of 2010. RESULTS: Of the 11,633 patients (55.4 ± 15.3 years; 65.7% women) with a serum glucose determination on the day of surgery, postoperative day 1, or postoperative day 2, 29.1% of patients were hyperglycemic. After controlling for clinical factors, those with hyperglycemia had a significantly increased risk of infection [odds ratio (OR) 2.0; 95% confidence interval (CI), 1.63-2.44], reoperative interventions (OR, 1.8; 95% CI, 1.41-2.3), and death (OR, 2.71; 95% CI, 1.72-4.28). Increased risk of poor outcomes was observed both for patients with and without diabetes. Those with hyperglycemia on the day of surgery who received insulin had no significant increase in infections (OR, 1.01; 95% CI, 0.72-1.42), reoperative interventions (OR, 1.29; 95% CI, 0.89-1.89), or deaths (OR, 1.21; 95% CI, 0.61-2.42). A dose-effect relationship was found between the effectiveness of insulin-related glucose control (worst 180-250 mg/dL, best <130 mg/dL) and adverse outcomes. CONCLUSIONS: Perioperative hyperglycemia was associated with adverse outcomes in general surgery patients with and without diabetes. However, patients with hyperglycemia who received insulin were at no greater risk than those with normal blood glucoses. Perioperative glucose evaluation and insulin administration in patients with hyperglycemia are important quality targets.

KW - Diabetes

KW - insulin

KW - perioperative hyperglycemia

KW - quality improvement

UR - http://www.scopus.com/inward/record.url?scp=84871551123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871551123&partnerID=8YFLogxK

U2 - 10.1097/SLA.0b013e31827b6bbc

DO - 10.1097/SLA.0b013e31827b6bbc

M3 - Article

C2 - 23235393

AN - SCOPUS:84871551123

VL - 257

SP - 8

EP - 14

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 1

ER -